{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T11:31:37Z","timestamp":1790767897577,"version":"4.1.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,11,23]],"date-time":"2020-11-23T00:00:00Z","timestamp":1606089600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,11,23]],"date-time":"2020-11-23T00:00:00Z","timestamp":1606089600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100008484","name":"BioMarin Pharmaceutical","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100008484","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Allievex"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Mucopolysaccharidosis type IIIB (MPS IIIB; Sanfilippo syndrome B) is an autosomal recessive lysosomal storage disorder caused by the deficiency of alpha-\n                    <jats:italic>N<\/jats:italic>\n                    -acetylglucosaminidase activity, leading to increased levels of nondegraded heparan sulfate (HS). A mouse model has been useful to evaluate novel treatments for MPS IIIB, but has limitations. In this study, we evaluated the naturally occurring canine model of MPS IIIB for the onset and progression of biochemical and neuropathological changes during the preclinical stages (onset approximately 24\u201330\u00a0months of age) of canine MPS IIIB disease. Even by 1\u00a0month of age, MPS IIIB dogs had elevated HS levels in brain and cerebrospinal fluid. Analysis of histopathology of several disease-relevant regions of the forebrain demonstrated progressive lysosomal storage and microglial activation despite a lack of cerebrocortical atrophy in the oldest animals studied. More pronounced histopathology changes were detected in the cerebellum, where progressive lysosomal storage, astrocytosis and microglial activation were observed. Microglial activation was particularly prominent in cerebellar white matter and within the deep cerebellar nuclei, where neuron loss also occurred. The findings in this study will form the basis of future assessments of therapeutic efficacy in this large animal disease model.\n                  <\/jats:p>","DOI":"10.1038\/s41598-020-77032-y","type":"journal-article","created":{"date-parts":[[2020,11,23]],"date-time":"2020-11-23T06:14:02Z","timestamp":1606112042000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Central nervous system pathology in preclinical MPS IIIB dogs reveals progressive changes in clinically relevant brain regions"],"prefix":"10.1038","volume":"10","author":[{"given":"Martin T.","family":"Egeland","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta M.","family":"Tarczyluk-Wells","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa M.","family":"Asmar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evan G.","family":"Adintori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger","family":"Lawrence","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth M.","family":"Snella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jackie K.","family":"Jens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brett E.","family":"Crawford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jill C. M.","family":"Wait","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"McCullagh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Pinkstaff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan D.","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N. Matthew","family":"Ellinwood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,11,23]]},"reference":[{"key":"77032_CR1","doi-asserted-by":"publisher","unstructured":"Elizabeth F. Neufeld; Joseph Muenzer. The Mucopolysaccharidoses | The Online Metabolic and Molecular Bases of Inherited Disease | OMMBID | McGraw-Hill Medical. https:\/\/doi.org\/10.1036\/ommbid.165","DOI":"10.1036\/ommbid.165"},{"key":"77032_CR2","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.ymgme.2013.07.016","volume":"111","author":"R Lawrence","year":"2014","unstructured":"Lawrence, R. et al. Glycan-based biomarkers for mucopolysaccharidoses. Mol. Genet. Metab. 111, 73\u201383 (2014).","journal-title":"Mol. Genet. Metab."},{"key":"77032_CR3","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.1073\/pnas.69.7.1720","volume":"69","author":"JS O\u2019Brien","year":"1972","unstructured":"O\u2019Brien, J. S. Sanfilippo syndrome: profound deficiency of alpha-acetylglucosaminidase activity in organs and skin fibroblasts from type-B patients. Proc. Natl. Acad. Sci. U. S. A. 69, 1720\u20131722 (1972).","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"77032_CR4","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1093\/hmg\/5.6.771","volume":"5","author":"B Weber","year":"1996","unstructured":"Weber, B., Blanch, L., Clements, P. R., Scott, H. S. & Hopwood, J. J. Cloning and expression of the gene involved in Sanfilippo B syndrome (mucopolysaccharidosis III B). Hum. Mol. Genet. 5, 771\u2013777 (1996).","journal-title":"Hum. Mol. Genet."},{"key":"77032_CR5","doi-asserted-by":"publisher","first-page":"6101","DOI":"10.1073\/pnas.93.12.6101","volume":"93","author":"HG Zhao","year":"1996","unstructured":"Zhao, H. G., Li, H. H., Bach, G., Schmidtchen, A. & Neufeld, E. F. The molecular basis of Sanfilippo syndrome type B. Proc. Natl. Acad. Sci. U. S. A. 93, 6101\u20136105 (1996).","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"77032_CR6","doi-asserted-by":"publisher","first-page":"14505","DOI":"10.1073\/pnas.96.25.14505","volume":"96","author":"HH Li","year":"1999","unstructured":"Li, H. H. et al. Mouse model of Sanfilippo syndrome type B produced by targeted disruption of the gene encoding alpha-N-acetylglucosaminidase. Proc. Natl. Acad. Sci. U. S. A. 96, 14505\u201314510 (1999).","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"77032_CR7","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.omtm.2017.05.009","volume":"6","author":"M Aoyagi-Scharber","year":"2017","unstructured":"Aoyagi-Scharber, M. et al. Clearance of heparan sulfate and attenuation of CNS pathology by intracerebroventricular BMN 250 in sanfilippo type B mice. Mol. Ther. Methods Clin. Dev. 6, 43\u201353 (2017).","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"77032_CR8","doi-asserted-by":"publisher","first-page":"14870","DOI":"10.1073\/pnas.1416660111","volume":"111","author":"S-H Kan","year":"2014","unstructured":"Kan, S.-H. et al. Delivery of an enzyme-IGFII fusion protein to the mouse brain is therapeutic for mucopolysaccharidosis type IIIB. Proc. Natl. Acad. Sci. U. S. A. 111, 14870\u201314875 (2014).","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"77032_CR9","doi-asserted-by":"publisher","first-page":"e35787","DOI":"10.1371\/journal.pone.0035787","volume":"7","author":"FL Wilkinson","year":"2012","unstructured":"Wilkinson, F. L. et al. Neuropathology in mouse models of mucopolysaccharidosis type I, IIIA and IIIB. PLoS ONE 7, e35787 (2012).","journal-title":"PLoS ONE"},{"key":"77032_CR10","doi-asserted-by":"publisher","first-page":"14870","DOI":"10.1073\/pnas.1416660111","volume":"111","author":"S-h Kan","year":"2014","unstructured":"Kan, S.-h et al. Delivery of an enzyme-IGFII fusion protein to the mouse brain is therapeutic for mucopolysaccharidosis type IIIB. Proc. Natl. Acad. Sci. 111, 14870\u201314875 (2014).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"77032_CR11","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1093\/hmg\/ddu727","volume":"24","author":"A Ribera","year":"2015","unstructured":"Ribera, A. et al. Biochemical, histological and functional correction of mucopolysaccharidosis type IIIB by intra-cerebrospinal fluid gene therapy. Hum. Mol. Genet. 24, 2078\u20132095 (2015).","journal-title":"Hum. Mol. Genet."},{"key":"77032_CR12","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1111\/j.1651-2227.2007.00211.x","volume":"96","author":"ME Haskins","year":"2007","unstructured":"Haskins, M. E. Animal models for mucopolysaccharidosis disorders and their clinical relevance. Acta Paediatr. 96, 56\u201362 (2007).","journal-title":"Acta Paediatr."},{"key":"77032_CR13","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1177\/0300985814529314","volume":"52","author":"C Palmieri","year":"2015","unstructured":"Palmieri, C., Giger, U., Wang, P., Pizarro, M. & Shivaprasad, H. L. Pathological and biochemical studies of mucopolysaccharidosis type IIIB (Sanfilippo syndrome type B) in juvenile emus (Dromaius novaehollandiae). Vet. Pathol. 52, 160\u2013169 (2015).","journal-title":"Vet. Pathol."},{"key":"77032_CR14","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1007\/s10545-007-0539-5","volume":"30","author":"L Karageorgos","year":"2007","unstructured":"Karageorgos, L., Hill, B., Bawden, M. J. & Hopwood, J. J. Bovine mucopolysaccharidosis type IIIB. J. Inherit. Metab. Dis. 30, 358\u2013364 (2007).","journal-title":"J. Inherit. Metab. Dis."},{"key":"77032_CR15","doi-asserted-by":"publisher","first-page":"bio035386","DOI":"10.1242\/bio.035386","volume":"7","author":"Q Yang","year":"2018","unstructured":"Yang, Q. et al. A model of mucopolysaccharidosis type IIIB in pigs. Biol. Open 7, bio035386 (2018).","journal-title":"Biol. Open"},{"key":"77032_CR16","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1038\/mt.2010.265","volume":"19","author":"NM Ellinwood","year":"2011","unstructured":"Ellinwood, N. M. et al. Safe, efficient, and reproducible gene therapy of the brain in the dog models of Sanfilippo and Hurler syndromes. Mol. Ther. 19, 251\u2013259 (2011).","journal-title":"Mol. Ther."},{"key":"77032_CR17","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1023\/A:1025177411938","volume":"26","author":"NM Ellinwood","year":"2003","unstructured":"Ellinwood, N. M. et al. A model of mucopolysaccharidosis IIIB (Sanfilippo syndrome type IIIB): N-acetyl-\u03b1-D-glucosaminidase deficiency in Schipperke dogs. J. Inherit. Metab. Dis. 26, 489\u2013504 (2003).","journal-title":"J. Inherit. Metab. Dis."},{"key":"77032_CR18","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1093\/brain\/awx311","volume":"141","author":"RJ Holley","year":"2018","unstructured":"Holley, R. J. et al. Macrophage enzyme and reduced inflammation drive brain correction of mucopolysaccharidosis IIIB by stem cell gene therapy. Brain 141, 99\u2013116 (2018).","journal-title":"Brain"},{"key":"77032_CR19","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.nbd.2008.06.004","volume":"32","author":"MJ Oswald","year":"2008","unstructured":"Oswald, M. J., Palmer, D. N., Kay, G. W., Barwell, K. J. & Cooper, J. D. Location and connectivity determine GABAergic interneuron survival in the brains of South Hampshire sheep with CLN6 neuronal ceroid lipofuscinosis. Neurobiol. Dis. 32, 50\u201365 (2008).","journal-title":"Neurobiol. Dis."},{"key":"77032_CR20","doi-asserted-by":"publisher","first-page":"1902","DOI":"10.1073\/pnas.252784899","volume":"100","author":"K Ohmi","year":"2003","unstructured":"Ohmi, K. et al. Activated microglia in cortex of mouse models of mucopolysaccharidoses I and IIIB. Proc. Natl. Acad. Sci. 100, 1902\u20131907 (2003).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"77032_CR21","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1161\/01.STR.32.5.1208","volume":"32","author":"D Ito","year":"2001","unstructured":"Ito, D., Tanaka, K., Suzuki, S., Dembo, T. & Fukuuchi, Y. Enhanced expression of Iba1, ionized calcium-binding adapter molecule 1, after transient focal cerebral ischemia in rat brain. Stroke 32, 1208\u20131215 (2001).","journal-title":"Stroke"},{"key":"77032_CR22","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1007\/s12291-014-0456-y","volume":"30","author":"MB Dave","year":"2015","unstructured":"Dave, M. B., Chawla, P. K., Dherai, A. J. & Ashavaid, T. F. Urinary glycosaminoglycan estimation as a routine clinical service. Indian J. Clin. Biochem. 30, 293\u2013297 (2015).","journal-title":"Indian J. Clin. Biochem."},{"key":"77032_CR23","doi-asserted-by":"publisher","first-page":"53A","DOI":"10.1203\/00006450-199904020-00318","volume":"45","author":"MS Hassan","year":"1999","unstructured":"Hassan, M. S., Reale, M. R. & Rosenfeld, L. Urinary glycosaminoglycans in newborns: correlation with gestational age. Pediatr. Res. 45, 53A-53A (1999).","journal-title":"Pediatr. Res."},{"key":"77032_CR24","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.ymgme.2014.09.009","volume":"114","author":"H Zhang","year":"2015","unstructured":"Zhang, H., Wood, T., Young, S. P. & Millington, D. S. A straightforward, quantitative ultra-performance liquid chromatography-tandem mass spectrometric method for heparan sulfate, dermatan sulfate and chondroitin sulfate in urine: an improved clinical screening test for the mucopolysaccharidoses. Mol. Genet. Metab. 114, 123\u2013128 (2015).","journal-title":"Mol. Genet. Metab."},{"key":"77032_CR25","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1093\/oxfordjournals.bmb.a070434","volume":"22","author":"AN Davison","year":"1966","unstructured":"Davison, A. N. & Dobbing, J. Myelination as a vulnerable period in brain development. Br. Med. Bull. 22, 40\u201344 (1966).","journal-title":"Br. Med. Bull."},{"key":"77032_CR26","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1111\/j.1440-1827.1976.tb00529.x","volume":"26","author":"K Shimamura","year":"1976","unstructured":"Shimamura, K. et al. Sanfilippo B syndrome\u2014a case report. Pathol. Int. 26, 739\u2013764 (1976).","journal-title":"Pathol. Int."},{"key":"77032_CR27","doi-asserted-by":"publisher","first-page":"3620","DOI":"10.1007\/s10803-017-3262-6","volume":"47","author":"C Wolfenden","year":"2017","unstructured":"Wolfenden, C., Wittkowski, A. & Hare, D. J. Symptoms of autism spectrum disorder (ASD) in individuals with mucopolysaccharide disease type III (sanfilippo syndrome): a systematic review. J. Autism Dev. Disord. 47, 3620\u20133633 (2017).","journal-title":"J. Autism Dev. Disord."},{"key":"77032_CR28","doi-asserted-by":"publisher","first-page":"420","DOI":"10.3389\/fnins.2015.00420","volume":"9","author":"DR Hampson","year":"2015","unstructured":"Hampson, D. R. & Blatt, G. J. Autism spectrum disorders and neuropathology of the cerebellum. Front. Neurosci. 9, 420 (2015).","journal-title":"Front. Neurosci."},{"key":"77032_CR29","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1016\/j.neuron.2014.07.016","volume":"83","author":"SSH Wang","year":"2014","unstructured":"Wang, S. S. H., Kloth, A. D. & Badura, A. The cerebellum, sensitive periods, and autism. Neuron 83, 518\u2013532 (2014).","journal-title":"Neuron"},{"key":"77032_CR30","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1111\/j.1399-0004.1985.tb00217.x","volume":"27","author":"J Marsh","year":"1985","unstructured":"Marsh, J. & Fensom, A. H. 4-Methylumbelliferyl alpha-N-acetylglucosaminidase activity for diagnosis of Sanfilippo B disease. Clin. Genet. 27, 258\u2013262 (1985).","journal-title":"Clin. Genet."},{"key":"77032_CR31","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1038\/nchembio.766","volume":"8","author":"R Lawrence","year":"2012","unstructured":"Lawrence, R. et al. Disease-specific non-reducing end carbohydrate biomarkers for mucopolysaccharidoses. Nat. Chem. Biol. 8, 197\u2013204 (2012).","journal-title":"Nat. Chem. Biol."},{"key":"77032_CR32","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1016\/j.nbd.2004.02.010","volume":"16","author":"E Bible","year":"2004","unstructured":"Bible, E., Gupta, P., Hofmann, S. L. & Cooper, J. D. Regional and cellular neuropathology in the palmitoyl protein thioesterase-1 null mutant mouse model of infantile neuronal ceroid lipofuscinosis. Neurobiol. Dis. 16, 346\u2013359 (2004).","journal-title":"Neurobiol. Dis."},{"key":"77032_CR33","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.ymgme.2014.09.004","volume":"114","author":"BR Vuillemenot","year":"2015","unstructured":"Vuillemenot, B. R. et al. Nonclinical evaluation of CNS-administered TPP1 enzyme replacement in canine CLN2 neuronal ceroid lipofuscinosis. Mol. Genet. Metab. 114, 281\u2013293 (2015).","journal-title":"Mol. Genet. Metab."},{"key":"77032_CR34","doi-asserted-by":"crossref","unstructured":"Palazzi, X. The Beagle Brain in Stereotaxic Coordinates (Springer, New York, 2011).","DOI":"10.1007\/978-1-4419-8372-5"},{"key":"77032_CR35","doi-asserted-by":"crossref","unstructured":"Gundersen, H. J. & Jensen, E. B. The efficiency of systematic sampling in stereology and its prediction. J. Microsc. 147, 229\u2013263 (1987).","DOI":"10.1111\/j.1365-2818.1987.tb02837.x"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-77032-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-77032-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-77032-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T18:56:03Z","timestamp":1670352963000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-77032-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,23]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["77032"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-77032-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,23]]},"assertion":[{"value":"15 January 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 November 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"RL, BEC, and JCMW are employees and stockholders of BioMarin Pharmaceutical Inc. EGA, EM and JP were employees of BioMarin Pharmaceutical Inc. at the time of the study. MTE, MTW, EMS, JKJ and NME have received research support from BioMarin Pharmaceutical Inc. JC also had research support from BioMarin Pharmaceutical Inc. in addition to Abeona Therapeutics Inc., Regenexbio Inc. and CereSpir Inc. MMA has no competing interests to declare.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"20365"}}